Skip to main content

Proteus

By Dave Muoio | 04:23 pm | August 20, 2020
Also: Centauri Health Solutions acquires HCFS; UCSF researchers detail smartphone PPG-based diabetes detection.
By Dave Muoio | 03:51 pm | June 16, 2020
The news comes months after reports that the company had furloughed staff and couldn't secure additional funding for its-ingestible sensor business.
By Dave Muoio | 06:01 pm | December 13, 2019
The industry is better off viewing the the floundering deals between Onduo and Sanofi, Proteus and Otsuka, and Pear and Sandoz as a learning opportunity.
By Dave Muoio | 01:34 pm | January 17, 2019
The sensor-embedded pill will be used to treat and monitor colorectal cancer patients receiving care at Fairview Health Services.
By Dave Muoio | 05:23 pm | October 15, 2018
As the Abilify MyCite platform nears a full rollout, the companies said they are looking forward to employing the technology toward additional mental health therapies.
By Laura Lovett | 04:58 pm | October 10, 2018
The ingesitble sensors will let providers look at adherence habits, activity levels and resting heart rate within a younger patient population. 
By Dave Muoio | 05:01 pm | August 30, 2018
The two companies are planning a limited initial deployment to gather additional real-world data before a wider release.
By Dave Muoio | 01:16 pm | August 21, 2018
Anthem Blue Cross and Blue Shield in Ohio has partnered with Propeller Health to provide sensor-equipped inhaler attachments to plan members with COPD.
By Dave Muoio | 03:39 pm | July 26, 2018
Proteus Digital Health’ pitch to track adherence using sensor-equipped pills has found another audience in the HIV prevention community.
By Dave Muoio | 05:03 pm | March 08, 2018
It’s still the early days, but the FDA’s approval of Proteus Digital Health and Otsuka Pharmaceuticals’ Abilify MyCite has changed the discussion of digital technology in healthcare.